- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01493505
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
22. februar 2017 oppdatert av: Amgen
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
The purpose of this study is to determine whether AMG 386 or AMG 386 Placebo in combination with Paclitaxel and Carboplatin are effective in the treatment of ovarian cancer.
Studieoversikt
Status
Avsluttet
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
1015
Fase
- Fase 3
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Bonheiden, Belgia, 2820
- Research Site
-
Brasschaat, Belgia, 2930
- Research Site
-
Bruxelles, Belgia, 1000
- Research Site
-
Charleroi, Belgia, 6000
- Research Site
-
Duffel, Belgia, 2570
- Research Site
-
Edegem, Belgia, 2650
- Research Site
-
Gent, Belgia, 9000
- Research Site
-
Hasselt, Belgia, 3500
- Research Site
-
Kortrijk, Belgia, 8500
- Research Site
-
Leuven, Belgia, 3000
- Research Site
-
Libramont, Belgia, 6800
- Research Site
-
Liège, Belgia, 4000
- Research Site
-
Namur, Belgia, 5000
- Research Site
-
Oostende, Belgia, 8400
- Research Site
-
Sint-Niklaas, Belgia, 9100
- Research Site
-
Turnhout, Belgia, 2300
- Research Site
-
Wilrijk, Belgia, 2610
- Research Site
-
Yvoir, Belgia, 5530
- Research Site
-
-
-
-
-
Quebec, Canada, G1R 2J6
- Research Site
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N2
- Research Site
-
Edmonton, Alberta, Canada, T6G 1Z2
- Research Site
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 1V7
- Research Site
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 5P9
- Research Site
-
London, Ontario, Canada, N6A 4L6
- Research Site
-
Sault Ste. Marie, Ontario, Canada, P6B 0A8
- Research Site
-
Toronto, Ontario, Canada, M5G 2M9
- Research Site
-
Toronto, Ontario, Canada, M4N 3M5
- Research Site
-
-
Quebec
-
Montreal, Quebec, Canada, H2L 4M1
- Research Site
-
-
-
-
-
Herlev, Danmark, 2730
- Research Site
-
København Ø, Danmark, 2100
- Research Site
-
Roskilde, Danmark, 4000
- Research Site
-
-
-
-
-
Chelyabinsk, Den russiske føderasjonen, 454087
- Research Site
-
Ivanovo, Den russiske føderasjonen, 153013
- Research Site
-
Krasnodar, Den russiske føderasjonen, 350040
- Research Site
-
Moscow, Den russiske føderasjonen, 115478
- Research Site
-
Obninsk, Den russiske føderasjonen, 249036
- Research Site
-
Pyatigorsk, Den russiske føderasjonen, 357502
- Research Site
-
Saint Petersburg, Den russiske føderasjonen, 197022
- Research Site
-
Ufa, Den russiske føderasjonen, 450054
- Research Site
-
Voronezh, Den russiske føderasjonen, 394000
- Research Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Forente stater, 35233
- Research Site
-
Mobile, Alabama, Forente stater, 36604
- Research Site
-
-
Alaska
-
Anchorage, Alaska, Forente stater, 99508
- Research Site
-
-
Arizona
-
Gilbert, Arizona, Forente stater, 85234
- Research Site
-
Peoria, Arizona, Forente stater, 85381
- Research Site
-
Phoenix, Arizona, Forente stater, 85013
- Research Site
-
Phoenix, Arizona, Forente stater, 85016
- Research Site
-
Tucson, Arizona, Forente stater, 85710
- Research Site
-
Tucson, Arizona, Forente stater, 85724-5024
- Research Site
-
-
California
-
Berkeley, California, Forente stater, 94704
- Research Site
-
Burbank, California, Forente stater, 91505
- Research Site
-
Concord, California, Forente stater, 94520
- Research Site
-
Corona, California, Forente stater, 92879
- Research Site
-
La Jolla, California, Forente stater, 92093-0957
- Research Site
-
Long Beach, California, Forente stater, 90806
- Research Site
-
Los Angeles, California, Forente stater, 90027
- Research Site
-
Orange, California, Forente stater, 92868
- Research Site
-
Oxnard, California, Forente stater, 93030
- Research Site
-
Rancho Mirage, California, Forente stater, 92270
- Research Site
-
Sacramento, California, Forente stater, 95817
- Research Site
-
Sacramento, California, Forente stater, 95816
- Research Site
-
San Diego, California, Forente stater, 92123
- Research Site
-
-
Colorado
-
Aurora, Colorado, Forente stater, 80045
- Research Site
-
Englewood, Colorado, Forente stater, 80113
- Research Site
-
-
Connecticut
-
Bridgeport, Connecticut, Forente stater, 06606
- Research Site
-
Farmington, Connecticut, Forente stater, 06030
- Research Site
-
Hartford, Connecticut, Forente stater, 06106
- Research Site
-
New Britain, Connecticut, Forente stater, 06050
- Research Site
-
Stamford, Connecticut, Forente stater, 06902
- Research Site
-
-
Florida
-
Clearwater, Florida, Forente stater, 33756
- Research Site
-
Hollywood, Florida, Forente stater, 33021
- Research Site
-
Miami, Florida, Forente stater, 33146
- Research Site
-
Orlando, Florida, Forente stater, 32804
- Research Site
-
Orlando, Florida, Forente stater, 32806
- Research Site
-
St Petersburg, Florida, Forente stater, 33701
- Research Site
-
Tampa, Florida, Forente stater, 33612
- Research Site
-
-
Georgia
-
Augusta, Georgia, Forente stater, 30912
- Research Site
-
Gainesville, Georgia, Forente stater, 30501
- Research Site
-
Macon, Georgia, Forente stater, 31201
- Research Site
-
Savannah, Georgia, Forente stater, 31404
- Research Site
-
-
Hawaii
-
Honolulu, Hawaii, Forente stater, 96826
- Research Site
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60612
- Research Site
-
Chicago, Illinois, Forente stater, 60637
- Research Site
-
Chicago, Illinois, Forente stater, 60611
- Research Site
-
Decatur, Illinois, Forente stater, 62526
- Research Site
-
Evanston, Illinois, Forente stater, 60201
- Research Site
-
Hinsdale, Illinois, Forente stater, 60521
- Research Site
-
Joliet, Illinois, Forente stater, 60435
- Research Site
-
Maywood, Illinois, Forente stater, 60153
- Research Site
-
Oak Lawn, Illinois, Forente stater, 60453
- Research Site
-
Park Ridge, Illinois, Forente stater, 60068
- Research Site
-
Urbana, Illinois, Forente stater, 61801
- Research Site
-
-
Indiana
-
Indianapolis, Indiana, Forente stater, 46237
- Research Site
-
Indianapolis, Indiana, Forente stater, 46260
- Research Site
-
Indianapolis, Indiana, Forente stater, 46202
- Research Site
-
Munster, Indiana, Forente stater, 46321
- Research Site
-
South Bend, Indiana, Forente stater, 46628
- Research Site
-
-
Iowa
-
Ames, Iowa, Forente stater, 50010
- Research Site
-
Iowa City, Iowa, Forente stater, 52242
- Research Site
-
-
Kansas
-
Kansas City, Kansas, Forente stater, 66160
- Research Site
-
-
Kentucky
-
Edgewood, Kentucky, Forente stater, 41017
- Research Site
-
Lexington, Kentucky, Forente stater, 40536
- Research Site
-
-
Louisiana
-
Covington, Louisiana, Forente stater, 70433
- Research Site
-
Lafayette, Louisiana, Forente stater, 70503
- Research Site
-
-
Maine
-
Scarborough, Maine, Forente stater, 04074
- Research Site
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21204
- Research Site
-
Baltimore, Maryland, Forente stater, 21237
- Research Site
-
Baltimore, Maryland, Forente stater, 21215
- Research Site
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02114
- Research Site
-
Burlington, Massachusetts, Forente stater, 01805
- Research Site
-
Danvers, Massachusetts, Forente stater, 01923
- Research Site
-
Worcester, Massachusetts, Forente stater, 01605
- Research Site
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48202
- Research Site
-
Detroit, Michigan, Forente stater, 48201
- Research Site
-
Kalamazoo, Michigan, Forente stater, 49007
- Research Site
-
-
Minnesota
-
Minneapolis, Minnesota, Forente stater, 55416
- Research Site
-
Rochester, Minnesota, Forente stater, 55905
- Research Site
-
St. Louis Park, Minnesota, Forente stater, 55426
- Research Site
-
-
Mississippi
-
Jackson, Mississippi, Forente stater, 39216
- Research Site
-
-
Missouri
-
Kansas City, Missouri, Forente stater, 64111
- Research Site
-
St Louis, Missouri, Forente stater, 63110
- Research Site
-
-
Montana
-
Billings, Montana, Forente stater, 59101
- Research Site
-
-
Nebraska
-
Lincoln, Nebraska, Forente stater, 68506
- Research Site
-
-
Nevada
-
Las Vegas, Nevada, Forente stater, 89169
- Research Site
-
Reno, Nevada, Forente stater, 89502
- Research Site
-
-
New Hampshire
-
Lebanon, New Hampshire, Forente stater, 03756
- Research Site
-
-
New Jersey
-
Hackensack, New Jersey, Forente stater, 07601
- Research Site
-
Neptune, New Jersey, Forente stater, 07753
- Research Site
-
Voorhees, New Jersey, Forente stater, 08043
- Research Site
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87131
- Research Site
-
Albuquerque, New Mexico, Forente stater, 87102
- Research Site
-
-
New York
-
Albany, New York, Forente stater, 12208
- Research Site
-
Brightwaters, New York, Forente stater, 11718
- Research Site
-
Bronx, New York, Forente stater, 10461
- Research Site
-
Buffalo, New York, Forente stater, 14263
- Research Site
-
Jamaica, New York, Forente stater, 11432
- Research Site
-
Lake Success, New York, Forente stater, 11042
- Research Site
-
New York, New York, Forente stater, 10032
- Research Site
-
New York, New York, Forente stater, 10065
- Research Site
-
New York, New York, Forente stater, 10029
- Research Site
-
Syracuse, New York, Forente stater, 13210
- Research Site
-
-
North Carolina
-
Asheville, North Carolina, Forente stater, 28806
- Research Site
-
Burlington, North Carolina, Forente stater, 27215
- Research Site
-
Chapel Hill, North Carolina, Forente stater, 27599-7570
- Research Site
-
Charlotte, North Carolina, Forente stater, 28204
- Research Site
-
Concord, North Carolina, Forente stater, 28025
- Research Site
-
Durham, North Carolina, Forente stater, 27710
- Research Site
-
Wilmington, North Carolina, Forente stater, 28402
- Research Site
-
Winston Salem, North Carolina, Forente stater, 27103
- Research Site
-
Winston Salem, North Carolina, Forente stater, 27157
- Research Site
-
-
North Dakota
-
Fargo, North Dakota, Forente stater, 58122
- Research Site
-
-
Ohio
-
Akron, Ohio, Forente stater, 44304
- Research Site
-
Canton, Ohio, Forente stater, 44710
- Research Site
-
Cincinnati, Ohio, Forente stater, 45220
- Research Site
-
Cincinnati, Ohio, Forente stater, 45267-0457
- Research Site
-
Cleveland, Ohio, Forente stater, 44195
- Research Site
-
Cleveland, Ohio, Forente stater, 44109
- Research Site
-
Cleveland, Ohio, Forente stater, 44106
- Research Site
-
Columbus, Ohio, Forente stater, 43210
- Research Site
-
Columbus, Ohio, Forente stater, 43214
- Research Site
-
Kettering, Ohio, Forente stater, 45429
- Research Site
-
Mayfield Heights, Ohio, Forente stater, 44124
- Research Site
-
Toledo, Ohio, Forente stater, 43614
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- Research Site
-
Tulsa, Oklahoma, Forente stater, 74136
- Research Site
-
-
Oregon
-
Bend, Oregon, Forente stater, 97701
- Research Site
-
-
Pennsylvania
-
Abington, Pennsylvania, Forente stater, 19001
- Research Site
-
Bethlehem, Pennsylvania, Forente stater, 18015
- Research Site
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Research Site
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Research Site
-
Pittsburgh, Pennsylvania, Forente stater, 15213
- Research Site
-
Pittsburgh, Pennsylvania, Forente stater, 15224
- Research Site
-
Radnor, Pennsylvania, Forente stater, 19087
- Research Site
-
West Reading, Pennsylvania, Forente stater, 19611
- Research Site
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02905
- Research Site
-
-
South Carolina
-
Charleston, South Carolina, Forente stater, 29425
- Research Site
-
Columbia, South Carolina, Forente stater, 29210
- Research Site
-
Greenville, South Carolina, Forente stater, 29605
- Research Site
-
Greenville, South Carolina, Forente stater, 29601
- Research Site
-
-
South Dakota
-
Sioux Falls, South Dakota, Forente stater, 57105
- Research Site
-
-
Tennessee
-
Chattanooga, Tennessee, Forente stater, 37403
- Research Site
-
-
Texas
-
Austin, Texas, Forente stater, 78731
- Research Site
-
Austin, Texas, Forente stater, 78701
- Research Site
-
Bedford, Texas, Forente stater, 76022
- Research Site
-
Dallas, Texas, Forente stater, 75246
- Research Site
-
Dallas, Texas, Forente stater, 75231
- Research Site
-
Dallas, Texas, Forente stater, 75390-9032
- Research Site
-
Galveston, Texas, Forente stater, 77555
- Research Site
-
Houston, Texas, Forente stater, 77030
- Research Site
-
San Antonio, Texas, Forente stater, 78217
- Research Site
-
The Woodlands, Texas, Forente stater, 77380
- Research Site
-
-
Utah
-
Ogden, Utah, Forente stater, 84403
- Research Site
-
-
Vermont
-
Burlington, Vermont, Forente stater, 05401
- Research Site
-
-
Virginia
-
Annandale, Virginia, Forente stater, 22003
- Research Site
-
Charlottesville, Virginia, Forente stater, 22908
- Research Site
-
Norfolk, Virginia, Forente stater, 23502
- Research Site
-
Roanoke, Virginia, Forente stater, 24016
- Research Site
-
Winchester, Virginia, Forente stater, 22601
- Research Site
-
Woodbridge, Virginia, Forente stater, 22191
- Research Site
-
-
Washington
-
Seattle, Washington, Forente stater, 98104
- Research Site
-
Tacoma, Washington, Forente stater, 98405
- Research Site
-
Wenatchee, Washington, Forente stater, 98801
- Research Site
-
-
Wisconsin
-
Green Bay, Wisconsin, Forente stater, 54301
- Research Site
-
Green Bay, Wisconsin, Forente stater, 54311
- Research Site
-
Marshfield, Wisconsin, Forente stater, 54449
- Research Site
-
Milwaukee, Wisconsin, Forente stater, 53226
- Research Site
-
Milwaukee, Wisconsin, Forente stater, 53215
- Research Site
-
Milwaukee, Wisconsin, Forente stater, 53233
- Research Site
-
Oshkosh, Wisconsin, Forente stater, 54904
- Research Site
-
Sheboygan, Wisconsin, Forente stater, 53081
- Research Site
-
Waukesha, Wisconsin, Forente stater, 53188
- Research Site
-
Wausau, Wisconsin, Forente stater, 54401
- Research Site
-
West Allis, Wisconsin, Forente stater, 53227
- Research Site
-
-
-
-
-
Athens, Hellas, 11527
- Research Site
-
Athens, Hellas, 11528
- Research Site
-
Athens, Hellas, 11522
- Research Site
-
Athens, Hellas, 14564
- Research Site
-
Larissa, Hellas, 41110
- Research Site
-
Patra, Hellas, 26500
- Research Site
-
Thessaloniki, Hellas, 56429
- Research Site
-
-
-
-
-
Hong Kong, Hong Kong
- Research Site
-
Kowloon, Hong Kong
- Research Site
-
New Territories, Hong Kong
- Research Site
-
-
-
-
-
Avellino, Italia, 83100
- Research Site
-
Aviano PN, Italia, 33081
- Research Site
-
Bari, Italia, 70124
- Research Site
-
Bologna, Italia, 40138
- Research Site
-
Brescia, Italia, 25123
- Research Site
-
Genova, Italia, 16132
- Research Site
-
Milano, Italia, 20141
- Research Site
-
Milano, Italia, 20133
- Research Site
-
Napoli, Italia, 80131
- Research Site
-
Novara, Italia, 28100
- Research Site
-
Palermo, Italia, 90126
- Research Site
-
Pisa, Italia, 56126
- Research Site
-
Roma, Italia, 00168
- Research Site
-
Roma, Italia, 00144
- Research Site
-
Torino, Italia, 10126
- Research Site
-
-
-
-
-
Tokyo, Japan, 105-8471
- Research Site
-
Tokyo, Japan, 160-8582
- Research Site
-
-
Aichi
-
Nagoya-city, Aichi, Japan, 464-8681
- Research Site
-
-
Chiba
-
Kashiwa, Chiba, Japan, 277-8567
- Research Site
-
-
Fukuoka
-
Fukuoka-shi, Fukuoka, Japan, 811-1395
- Research Site
-
Kurume-city, Fukuoka, Japan, 830-0011
- Research Site
-
-
Hiroshima
-
Kure-city, Hiroshima, Japan, 737-0023
- Research Site
-
-
Hokkaido
-
Sapporo-city, Hokkaido, Japan, 003-0804
- Research Site
-
-
Iwate
-
Morioka-city, Iwate, Japan, 020-8505
- Research Site
-
-
Saitama
-
Kitaadachi-gun, Saitama, Japan, 362-0806
- Research Site
-
-
Shizuoka
-
Suntou-gun, Shizuoka, Japan, 411-8777
- Research Site
-
-
Tottori
-
Yonago-city, Tottori, Japan, 683-8504
- Research Site
-
-
-
-
-
Goyang-si, Gyeonggi-do, Korea, Republikken, 410-769
- Research Site
-
Seoul, Korea, Republikken, 135-710
- Research Site
-
Seoul, Korea, Republikken, 138-736
- Research Site
-
Seoul, Korea, Republikken, 110-744
- Research Site
-
-
-
-
-
Deventer, Nederland, 7416 SE
- Research Site
-
Leiden, Nederland, 2333 ZA
- Research Site
-
Nijmegen, Nederland, 6525 GA
- Research Site
-
Rotterdam, Nederland, 3015 CE
- Research Site
-
-
-
-
-
Madrid, Spania, 28034
- Research Site
-
Madrid, Spania, 28046
- Research Site
-
Madrid, Spania, 28041
- Research Site
-
Madrid, Spania, 28040
- Research Site
-
Madrid, Spania, 28009
- Research Site
-
Madrid, Spania, 28050
- Research Site
-
Madrid, Spania, 28033
- Research Site
-
Madrid, Spania, 28922
- Research Site
-
-
Aragón
-
Zaragoza, Aragón, Spania, 50009
- Research Site
-
-
Asturias
-
Oviedo, Asturias, Spania, 33006
- Research Site
-
-
Baleares
-
Palma de Mallorca, Baleares, Spania, 07198
- Research Site
-
-
Cataluña
-
Badalona, Cataluña, Spania, 08916
- Research Site
-
Barcelona, Cataluña, Spania, 08035
- Research Site
-
Girona, Cataluña, Spania, 17007
- Research Site
-
Lleida, Cataluña, Spania, 25198
- Research Site
-
-
Comunidad Valenciana
-
Valencia, Comunidad Valenciana, Spania, 46009
- Research Site
-
Valencia, Comunidad Valenciana, Spania, 46014
- Research Site
-
Valencia, Comunidad Valenciana, Spania, 46026
- Research Site
-
-
Murcia
-
El Palmar, Murcia, Spania, 30120
- Research Site
-
-
-
-
-
Berlin, Tyskland, 13353
- Research Site
-
Dresden, Tyskland, 01307
- Research Site
-
Düsseldorf, Tyskland, 40225
- Research Site
-
Düsseldorf, Tyskland, 40217
- Research Site
-
Erlangen, Tyskland, 91054
- Research Site
-
Essen, Tyskland, 45136
- Research Site
-
Essen, Tyskland, 45147
- Research Site
-
Frankfurt am Main, Tyskland, 65929
- Research Site
-
Frankfurt am Main, Tyskland, 60590
- Research Site
-
Freiburg, Tyskland, 79106
- Research Site
-
Hamburg, Tyskland, 20246
- Research Site
-
Hannover, Tyskland, 30625
- Research Site
-
Hannover, Tyskland, 30177
- Research Site
-
Kiel, Tyskland, 24105
- Research Site
-
Konstanz, Tyskland, 78464
- Research Site
-
Leipzig, Tyskland, 04103
- Research Site
-
Ludwigsburg, Tyskland, 71640
- Research Site
-
München, Tyskland, 80337
- Research Site
-
München, Tyskland, 81675
- Research Site
-
München, Tyskland, 81377
- Research Site
-
Oldenburg, Tyskland, 26121
- Research Site
-
Ravensburg, Tyskland, 88212
- Research Site
-
Rostock, Tyskland, 18059
- Research Site
-
Stuttgart, Tyskland, 70374
- Research Site
-
Tübingen, Tyskland, 72076
- Research Site
-
Ulm, Tyskland, 89075
- Research Site
-
-
-
-
-
Graz, Østerrike, 8036
- Research Site
-
Graz, Østerrike, 8020
- Research Site
-
Innsbruck, Østerrike, 6020
- Research Site
-
Linz, Østerrike, 4010
- Research Site
-
Linz, Østerrike, 4020
- Research Site
-
Salzburg, Østerrike, 5020
- Research Site
-
Wien, Østerrike, 1130
- Research Site
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion Criteria:
- Female subjects 18 years of age or older with FIGO Stages III-IV epithelial ovarian, primary peritoneal or fallopian tube cancer with an indication for first-line treatment with paclitaxel and carboplatin x 6 cycles (Subjects with pseudomyxoma, mesothelioma, adenocarcinoma with an unknown primary tumour, carcinosarcoma, sarcoma, mucinous or neuroendocrine histology are excluded
- Subjects with FIGO Stage IIIA or IIIB disease must have undergone PDS for ovarian, primary peritoneal or fallopian tube cancer within 12 weeks prior to randomization
- Subjects with FIGO Stage IIIC or IV disease must either:
- Undergo PDS for epithelial ovarian, primary peritoneal or fallopian tube cancer within 12 weeks prior to randomization or
- Plan to have IDS following 3 cycles of paclitaxel and carboplatin plus AMG 386 or AMG 386 placebo for biopsy proven epithelial ovarian, primary peritoneal or fallopian tube cancer
- ECOG performance status of 0 or 1
- Adequate bone marrow, renal and hepatic function
Exclusion Criteria:
- Prior use of any anticancer therapy or experimental therapy for epithelial ovarian, primary peritoneal or fallopian tube cancer
- Previous abdominal and/or pelvic external beam radiotherapy
- History of central nervous metastasis
- History of arterial or venous thromboembolism within 12 months prior to randomization
- Clinically significant cardiovascular disease within 12 months prior to randomization
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Placebo komparator: Placebo
Placebo Paclitaxel Carboplatin
|
Paclitaxel 175 mg/m2 3 hour IV Q3W (6 cycles)
AMG 386 Placebo IV QW (until progression or unacceptable toxicity develops)
Carboplatin AUC 5 or 6 IV Q3W (6 cycles)
|
|
Aktiv komparator: AMG 386
AMG 386 Paclitaxel Carboplatin
|
Paclitaxel 175 mg/m2 3 hour IV Q3W (6 cycles)
Carboplatin AUC 5 or 6 IV Q3W (6 cycles)
AMG 386 15mg/kg IV QW (until progression or unacceptable toxicity develops)
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Progresjonsfri overlevelse
Tidsramme: 3 år
|
3 år
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Total overlevelse (OS)
Tidsramme: 5 år
|
5 år
|
|
|
Incidence of adverse events and significant laboratory abnormalities
Tidsramme: 4 years
|
4 years
|
|
|
Pharmacokinetics of AMG 386 (Cmax and Cmin)
Tidsramme: 1 year
|
pre-dose weeks 1, 7, 10, 19 and within 10 minutes post dose week 1, 7
|
1 year
|
|
Incidence of anti-AMG 386 antibody formation
Tidsramme: 4 years
|
pre-dose weeks 1, 10, 19
|
4 years
|
|
Patient reported ovarian cancer-specific symptoms and health related quality of life
Tidsramme: 4 years
|
4 years
|
|
|
Patient reported status as measured by the EuroQOL (EQ-5D)
Tidsramme: 4 years
|
4 years
|
|
|
AMG 386 exposure-response relationships for PFS and OS
Tidsramme: 4 years
|
4 years
|
|
|
Correlation of serum biomarkers with measures of response
Tidsramme: 4 years
|
4 years
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Fujiwara K, Monk BJ, Lhomme C, Coleman RL, Brize A, Oaknin A, Ray-Coquard I, Fabbro M, Provencher D, Bamias A, Vergote I, DeCensi A, Zhang K, Vogl FD, Bach BA, Raspagliesi F. Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1). Ann Oncol. 2016 Jun;27(6):1006-1013. doi: 10.1093/annonc/mdw147. Epub 2016 Mar 30.
- Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7.
Hjelpsomme linker
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. januar 2012
Primær fullføring (Faktiske)
1. mars 2016
Studiet fullført (Faktiske)
1. desember 2016
Datoer for studieregistrering
Først innsendt
29. september 2011
Først innsendt som oppfylte QC-kriteriene
15. desember 2011
Først lagt ut (Anslag)
16. desember 2011
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
23. februar 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
22. februar 2017
Sist bekreftet
1. februar 2017
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Neoplasmer etter histologisk type
- Neoplasmer
- Urogenitale neoplasmer
- Neoplasmer etter nettsted
- Karsinom
- Neoplasmer, kjertel og epitel
- Genitale neoplasmer, kvinnelige
- Sykdommer i det endokrine systemet
- Sykdommer i eggstokkene
- Adnexal sykdommer
- Gonadal lidelser
- Neoplasmer i endokrine kjertel
- Eggledersykdommer
- Neoplasmer i eggstokkene
- Egglederneoplasmer
- Karsinom, ovarieepitel
- Fysiologiske effekter av legemidler
- Molekylære mekanismer for farmakologisk virkning
- Antineoplastiske midler
- Tubulin modulatorer
- Antimitotiske midler
- Mitosemodulatorer
- Antineoplastiske midler, fytogene
- Angiogenese-hemmere
- Angiogenesemodulerende midler
- Vekststoffer
- Veksthemmere
- Karboplatin
- Paklitaksel
- Trebananib
Andre studie-ID-numre
- 20101129
- TRINOVA-3 20101129/ENGOT-ov2
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .